This program will provide perspectives from experts who serve on the National Comprehensive Cancer Network (NCCN) CLL/SLL panel on the latest clinical developments and clinical guidance on recent data and emerging treatment advances in the personalization of care of patients with CLL/SLL.
- Provider:National Comprehensive Cancer Network
- Activity Link: https://education.nccn.org/CLL2024
- Start Date: 2024-07-23 05:00:00
- End Date: 2024-07-23 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - Commercial Support: Source: AbbVie (Any division) - Amount: 0.0 - Is Kind Support: False Source: BeiGene - Amount: 0.0 - Is Kind Support: False Source: Janssen (Any division) - Amount: 0.0 - Is Kind Support: False Source: Lilly (Any division) - Amount: 0.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Community/Population Health, Learner Knowledge, Learner/Team Competence, Learner/Team Performance, Patient Health
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest